Additionally, NEAT1 was effective in discriminating between patients with liver failure, showing 78.95% sensitivity and 60% specificity (AUC = 0.71; cut-off > 0.20; p < 0.006) (Figure 3D). Here, NEAT1 is linked to Hepatic failure.